One-hundred forty-six patients were studied with the aim of procedure evaluation & detection of predictors and rate of restenosis. Our results revealed diabetes mellitus, dyslipidemia and positive family history of CAD as strong predictors of clinical, scintigraphic and angiographic restenosis with reported incidence of clinical adverse events in 39.6% and angiographic restenosis in 38.4% with marked reduction in the incidence of events in patients treated with drug-eluting stents.